New product licenses total 670 in first half

Published: 2006-07-21 07:00:00

Updated: 2006-07-21 07:00:00

Even amid data fabrication of bioequivalence, licenses for new products in the first half of this year totaled 670 items, according to a report released by the Korea Food and Drug Administration (KFDA).

Details of new product licenses in the January-June period were as follows: 98 items in Jan...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK